Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation

Nature Communications

Volumn 5, Issue , 2014, Pages

  Lin, Chih Chung ^a   Bradstreet, Tara R ^a   Schwarzkopf, Elizabeth A ^a   Sim, Julia ^b   Carrero, Javier A ^a   Chou, Chun ^a   Cook, Lindsey E ^a   Egawa, Takeshi ^a   Taneja, Reshma ^a   Murphy, Theresa L ^a   Russell, John H ^b   Edelson, Brian T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR E40; CD11B ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR MONOCLONAL ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; RAG1 PROTEIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

GENE EXPRESSION; IMMUNE SYSTEM; PATHOGENICITY; PROTEIN; RODENT; SECRETION;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CHROMATIN IMMUNOPRECIPITATION; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE LOCUS; IMMUNIZATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MICROGLIA; MOUSE; NONHUMAN; PATHOGENICITY; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SPINAL CORD TRANSSECTION; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; RECEPTORS, INTERLEUKIN-10; TH1 CELLS; TH17 CELLS;

EID: 84898736806     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4551     Document Type: Article

References (70)

1. Mendel, I., Kerlero de Rosbo, N. &Ben-Nun, A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951-1959 (1995).
2. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005). (Pubitemid 41541791)
3. Becher, B. &Segal, B. M. T(H)17 cytokines in autoimmune neuroinflammation. Curr. Opin. Immunol. 23, 707-712 (2011).
4. Chu, C. Q., Wittmer, S. &Dalton, D. K. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123-128 (2000). (Pubitemid 30470813)
5. Haak, S. et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro- inflammation in mice. J. Clin. Invest. 119, 61-69 (2009).
6. Coquet, J. M., Chakravarti, S., Smyth, M. J. &Godfrey, D. I. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180, 7097-7101 (2008).
7. Kreymborg, K. et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098-8104 (2007).
8. Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. &Segal, B. M. IL-12- and IL-23- modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205, 1535-1541 (2008). (Pubitemid 351962016)
9. Kroenke, M. A., Chensue, S. W. &Segal, B. M. EAE mediated by a non-IFNgamma/ non-IL-17 pathway. Eur. J. Immunol. 40, 2340-2348 (2010).
10. Codarri, L. et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560-567 (2011).
11. El-Behi, M. et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568-575 (2011).
12. McGeachy, M. J. GM-CSF: the secret weapon in the T(H)17 arsenal. Nat. Immunol. 12, 521-522 (2011).
13. Lukens, J. R., Barr, M. J., Chaplin, D. D., Chi, H. &Kanneganti, T. D. Inflammasome-derived IL-1beta regulates the production of GM-CSF by CD4(+) T cells and gammadelta T cells. J. Immunol. 188, 3107-3115 (2012).
14. Shannon, M. F., Coles, L. S., Vadas, M. A. &Cockerill, P. N. Signals for activation of the GM-CSF promoter and enhancer in T cells. Crit. Rev. Immunol. 17, 301-323 (1997). (Pubitemid 27268459)
15. Holloway, A. F., Rao, S., Chen, X. &Shannon, M. F. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins. J. Exp. Med. 197, 413-423 (2003). (Pubitemid 36278598)
16. Brettingham-Moore, K. H., Rao, S., Juelich, T., Shannon, M. F. &Holloway, A. F. GM- CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements. Nucleic Acids Res. 33, 225-234 (2005). (Pubitemid 40276944)
17. Gerondakis, S. et al. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl Acad. Sci. USA 93, 3405-3409 (1996). (Pubitemid 26125633)
18. Campbell, I. K. et al. Differentiation of inflammatory dendritic cells is mediated by NF- kappaB1-dependent GM-CSF production in CD4 T cells. J. Immunol. 186, 5468-5477 (2011).
19. Bakshi, R. et al. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J. Cell Physiol. 225, 569-576 (2010).
20. Bettelli, E., Nicholson, L. B. &Kuchroo, V. K. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. J. Autoimmun. 20, 265-267 (2003). (Pubitemid 36677515)
21. Yu, P. et al. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J. Immunol. 174, 6772-6780 (2005). (Pubitemid 40705640)
22. Fitzgerald, D. C. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372-1379 (2007). (Pubitemid 350131174)
23. Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10- producing anti-inflammatory T cells. Nat. Immunol. 8, 1380-1389 (2007). (Pubitemid 350131175)
24. McGeachy, M. J. et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390-1397 (2007). (Pubitemid 350138974)
25. Ghoreschi, K. et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967-971 (2010).
26. Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991-999 (2012).
27. Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. &Tedder, T. F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118, 3420-3430 (2008).
28. Segal, B. M., Dwyer, B. K. &Shevach, E. M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187, 537-546 (1998). (Pubitemid 28093356)
29. Bettelli, E. et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161, 3299-3306 (1998).
30. Samoilova, E. B., Horton, J. L. &Chen, Y. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Cell Immunol. 188, 118-124 (1998). (Pubitemid 28493564)
31. Saraiva, M. &O'Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181 (2010).
32. Motomura, Y. et al. The transcription factor E4BP4 regulates the production of IL-10 andIL-13 in CD4+ T cells. Nat. Immunol. 12, 450-459 (2011).
33. Saraiva, M. et al. Interleukin-10 production by Th1 cells requires interleukin- 12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31, 209-219 (2009).
34. Xu, J. et al. c-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 182, 6226-6236 (2009).
35. Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854-861 (2010).
36. Yamada, K. &Miyamoto, K. Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3; their gene expressions are regulated by multiple extracellular stimuli. Front. Biosci. 10, 3151-3171 (2005). (Pubitemid 40910554)
37. Sun, H., Ghaffari, S. &Taneja, R. BHLH-orange transcription factors in development and cancer. Transl. Oncogenomics 2, 107-120 (2007).
38. Miyazaki, K. et al. The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells. J. Immunol. 185, 7330-7339 (2010).
39. Sun, H., Lu, B., Li, R. Q., Flavell, R. A. &Taneja, R. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol. 2, 1040-1047 (2001). (Pubitemid 33069499)
40. Liu, Z. et al. Dec2 promotes Th2 cell differentiation by enhancing IL-2R signaling. J. Immunol. 183, 6320-6329 (2009).
41. Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331-341 (2009).
42. Lees, J. R., Iwakura, Y. &Russell, J. H. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. J. Immunol. 180, 8066-8072 (2008).
43. Matsuzaki, G., Yamada, H., Kishihara, K., Yoshikai, Y. &Nomoto, K. Mechanism of murine Vgamma1+ gamma delta T cell-mediated innate immune response against Listeria monocytogenes infection. Eur. J. Immunol. 32, 928-935 (2002). (Pubitemid 34428807)
44. ENCODE Project Consortium. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9, e1001046 (2011).
45. Wurster, A. L., Precht, P. &Pazin, M. J. NF-kappaB and BRG1 bind a distal regulatory element in the IL-3/GM-CSF locus. Mol. Immunol. 48, 2178-2188 (2011).
46. Lee, C. G. et al. A distal cis-regulatory element, CNS-9, controls NFAT1 and IRF4- mediated IL-10 gene activation in T helper cells. Mol. Immunol. 46, 613-621 (2009).
47. Li, P. et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543-546 (2012).
48. Vahedi, G. et al. STATs shape the active enhancer landscape of T cell populations. Cell 151, 981-993 (2012).
49. Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012).
50. Nakayamada, S. et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 35, 919-931 (2011).
51. McQualter, J. L. et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873-882 (2001).
52. Jager, A., Dardalhon, V., Sobel, R. A., Bettelli, E. &Kuchroo, V. K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169-7177 (2009).
53. Brustle, A. et al. The NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cells. J. Clin. Invest. 122, 4698-4709 (2012).
54. Yang, X. O. et al. Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment. Nat. Immunol. 10, 1260-1266 (2009).
55. Li, Y. et al. The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter. Oncogene 25, 3296-3306 (2006). (Pubitemid 43846314)
56. Qian, Y., Zhang, J., Jung, Y. S. &Chen, X. DEC1 coordinates with HDAC8 to differentially regulate TAp73 and DNp73 expression. PLoS One 9, e84015 (2014).
57. Martínez-Llordella, M. et al. CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response. J. Exp. Med. 210, 1603-1619 (2013).
58. Jiang, X. et al. BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J. Neurosci. 28, 1118-1130 (2008). (Pubitemid 351186340)
59. Burmester, G. R. et al. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann. Rheum. Dis. 72, 1445-1452 (2013).
60. Fairfax, K. C. et al. IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease. PLoS Pathog. 8, e1002490 (2012).
61. Wei, G. et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30, 155-167 (2009).
62. Bailey, T. L. DREME: motif discovery in transcription factor ChIP-seq data. Bioinformatics 27, 1653-1659 (2011).
63. Machanick, P. &Bailey, T. L. MEME-ChIP: motif analysis of large DNA data sets. Bioinformatics 27, 1696-1697 (2011).
64. St-Pierre, B., Flock, G., Zacksenhaus, E. &Egan, S. E. Stra13 homodimers repress transcription through class B E-box elements. J. Biol. Chem. 277, 46544-46551 (2002). (Pubitemid 35417652)
65. Wei, G. et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 35, 299-311 (2011).
66. De, S. et al. Dynamic BRG1 recruitment during T helper differentiation and activation reveals distal regulatory elements. Mol. Cell Biol. 31, 1512-1527 (2011).
67. Goecks, J., Nekrutenko, A. &Taylor, J. The Galaxy Team. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 11, R86 (2010).
68. Blankenberg, D. et al. Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. Chapter 19 Unit 19.10 1-21 (2010).
69. Giardine, B. et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 15, 1451-1455 (2005). (Pubitemid 41400913)
70. Ranganath, S. et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 15, 3822-3826 (1998). (Pubitemid 28468954)